Abbmira Therapeutics
Pre-clinicalTransforming Cancer Therapy Through Immune Reprogramming
Founded
2021
Focus
Small Molecules
About
Transforming Cancer Therapy Through Immune Reprogramming
Funding History
1Total raised: $4.2M
Seed$4.2MUndisclosedMar 15, 2022
Company Info
TypePrivate
Founded2021
LocationBasel, Switzerland
StagePre-clinical
Contact
SIMILAR COMPANIES
3Brain
Pre-clinical · Zug
Baxiva
Pre-clinical · Zug
AC Bioscience
Pre-clinical · Lausanne
Abrinca Genomics
Pre-clinical · Zurich
AdipoGen
Pre-clinical · Liestal
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile